Cited by 97Neuroscience and Neuropharmacology ResearchMemory and Neural MechanismsAlzheimer's disease research and treatments

Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders

Open access
Ratner, Marcia H., Kumaresan, Vidhya, Farb, David H.·2019·Frontiers in Endocrinology

Abstract

Memory dysfunction is a symptomatic feature of many neurologic and neuropsychiatric disorders; however, the basic underlying mechanisms of memory and altered states of circuitry function associated with disorders of memory remain a vast unexplored territory. The initial discovery of endogenous neurosteroids triggered a quest to elucidate their role as neuromodulators in normal and diseased brain function. In this review, based on the perspective of our own research, the advances leading to the discovery of positive and negative neurosteroid allosteric modulators of GABA type-A (GABAA), NMDA, and non-NMDA type glutamate receptors are brought together in a historical and conceptual framework. We extend the analysis toward a state-of-the art view of how neurosteroid modulation of neural circuitry function may affect memory and memory deficits. By aggregating the results from multiple laboratories using both animal models for disease and human clinical research on neuropsychiatric and age-related neurodegenerative disorders, elements of a circuitry level view begins to emerge. Lastly, the effects of both endogenously active and exogenously administered neurosteroids on neural networks across the life span of women and men point to a possible underlying pharmacological connectome by which these neuromodulators might act to modulate memory across diverse altered states of mind.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2019.00169

Cites

408 of 408 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This prediction is consistent with reported correlations between neurosteroids and a series of neurological disorders, including migraine, postpartum-depression, epilepsy, anxiety, cognitive and psychiatric disorders.

    “Such a prediction is consistent with reported correlations between neurosteroids and a series of neurological disorders, including migraine, postpartum-depression, epilepsy, anxiety, cognitive and psychiatric disorders [56,144,145].”

    From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [144]

    The Introduction’s Table 2 reports associations involving neurosteroids in Alzheimer’s disease and catamenial epilepsy, and the review discusses depression, schizophrenia, and anxiety disorders. It does not establish the claimed series in full: no passage found addresses migraine, and postpartum depression appears in the References as a brexanolone-treatment study rather than a reported correlation. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

4 of the 412 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [119]Weaver CE Land MB Malayev AA Purdy RH Richards KG Gibbs TT Farb DH. Geometry and charge determine the pharmacological effects of steroids on the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther. (2000) 293: 747– 54. 10869372

Cited by

Sorted by citations

Authors
Ratner, M. H., Kumaresan, V., & Farb, D. H.
Affiliations
Boston University (US)
Corresponding author
Farb, David H.
Venue
Frontiers in Endocrinology
Published
2019-04-09
Volume
10
Pages
169-169
ISSN
1664-2392 (ISSN-L)
OpenAlex
W2939309394
Cited by
96
References
412
Citations by year
2026: 5 · 2025: 4 · 2024: 14 · 2023: 16 · 2022: 18 · 2021: 22 · 2020: 15 · 2019: 1 · 2018: 1
FWCI
1.86
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Endocrinology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute on Aging (R21AG056947)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
neurosteroids, memory, GABAA receptor, NMDA receptor, non-NMDA receptors, allosteric modulation, neuromodulation, neural circuits, memory impairment, neuropsychiatric disorders, neurodegenerative diseases, sex differences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review